Combining TIGIT blockade with MDSC inhibition hinders breast cancer bone metastasis by activating anti-tumor immunity
RNA-seq (gene expression) · mouse · 55 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 55 samples: 16 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor ImmunityCancer discovery · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE253444_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1065817 and SRA study SRP484182. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 55 samples.
How we read this: 16 replicated groups read from 55 sample titles; they account for 55 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8020774 Granulocytes Normal 1 Granulocytes Normal
- GSM8020775 Granulocytes Normal 2 Granulocytes Normal
- GSM8020776 Granulocytes Normal 3 Granulocytes Normal
- GSM8020777 Granulocytes Normal 4 Granulocytes Normal
- GSM8020778 Granulocytes Premet 1 Granulocytes Premet
- GSM8020779 Granulocytes Premet 2 Granulocytes Premet
- GSM8020780 Granulocytes Premet 3 Granulocytes Premet
- GSM8020781 Granulocytes Premet 4 Granulocytes Premet
- GSM8020782 Granulocytes Periph 1 Granulocytes Periph
- GSM8020783 Granulocytes Periph 2 Granulocytes Periph
- GSM8020784 Granulocytes Periph 3 Granulocytes Periph
- GSM8020785 Granulocytes Periph 4 Granulocytes Periph
- GSM8020786 Granulocytes Met 1 Granulocytes Met
- GSM8020787 Granulocytes Met 2 Granulocytes Met
- GSM8020788 Granulocytes Met 3 Granulocytes Met
- GSM8020789 CD4 Normal 1 CD4 Normal
- GSM8020790 CD4 Normal 2 CD4 Normal
- GSM8020791 CD4 Normal 3 CD4 Normal
- GSM8020792 CD4 Normal 4 CD4 Normal
- GSM8020793 CD4 Premet 1 CD4 Premet
- GSM8020794 CD4 Premet 2 CD4 Premet
- GSM8020795 CD4 Premet 3 CD4 Premet
- GSM8020796 CD4 Premet 4 CD4 Premet
- GSM8020797 CD4 Periph 1 CD4 Periph
- GSM8020798 CD4 Periph 2 CD4 Periph
- GSM8020799 CD4 Periph 3 CD4 Periph
- GSM8020800 CD4 Periph 4 CD4 Periph
- GSM8020801 CD4 Met 1 CD4 Met
- GSM8020802 CD4 Met 2 CD4 Met
- GSM8020803 CD4 Met 3 CD4 Met
- GSM8020804 CD8 Normal 1 CD8 Normal
- GSM8020805 CD8 Normal 2 CD8 Normal
- GSM8020806 CD8 Normal 3 CD8 Normal
- GSM8020807 CD8 Normal 4 CD8 Normal
- GSM8020808 CD8 Premet 1 CD8 Premet
- GSM8020809 CD8 Premet 2 CD8 Premet
- GSM8020810 CD8 Premet 3 CD8 Premet
- GSM8020811 CD8 Premet 4 CD8 Premet
- GSM8020812 CD8 Periph 1 CD8 Periph
- GSM8020813 CD8 Periph 2 CD8 Periph
+ 15 more — browse all 55 samples with per-sample file links →
- GSE207029 Blockade of avb8 integrin synergizes with checkpoint inhibition to enhance anti-tumor immunity through Cxcl9-dependent augmentation of CD8+ T cell cytotoxicity 12 samples shares inhibition, anti-tumor, blockade
- GSE260816 Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells 46 samples shares tigit, blockade
- GSE322775 Coordinated immune activation following KRAS inhibition reveals molecular pathways that potentiate and limit anti-tumor immunity 47 samples shares inhibition, anti-tumor
- GSE334363 PDE5a Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking Through a Non-canonical cGMP-Dependent Pathway 18 samples shares inhibition, metastasis
- GSE268000 Anti-tumor Efficacy of HRS-4642 and Its Potential Combination with Proteasome Inhibition in KRAS G12D-mutant Cancer 12 samples shares inhibition, anti-tumor
- GSE291447 Targeting CD11b+ regulatory B cells via RAS/RAF/PI3K pathway inhibition augments response to immune checkpoint blockade or CD40 agonism in metastatic melanoma 60 samples shares inhibition, blockade
- GSE222996 The immune landscape of the “deregulated host response” in sepsis: newly emerging MDSCs with high expression of CD47 leads to B cell suppression via App-CD74 signaling [RNA-seq] 61 samples shares mdsc
- GSE318028 Pharmacological inhibition of FKBP51 mitigates early life adversity-induced social deficits 246 samples shares inhibition
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.